These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 10853850

  • 41. [Tolerability of Asacard--controlled-release aspirin and aspirin-induced asthma].
    Bochenek G, Swierczyńska M, Nizankowska-Mogilnicka E, Vivet P, Gicquel M, Szczeklik A.
    Pol Arch Med Wewn; 2002 Mar; 107(3):249-56. PubMed ID: 12107984
    [Abstract] [Full Text] [Related]

  • 42. Extrabronchial symptoms and late phase reaction enhance the diagnostic value of aspirin bronchial challenge.
    Tworek D, Zielińska-Wyderkiewicz E, Górski P, Kuna P.
    Postepy Dermatol Alergol; 2015 Dec; 32(6):431-6. PubMed ID: 26755906
    [Abstract] [Full Text] [Related]

  • 43. Safety of meloxicam in aspirin-hypersensitive patients with asthma and/or nasal polyps. A challenge-proven study.
    Bavbek S, Dursun AB, Dursun E, Eryilmaz A, Misirligil Z.
    Int Arch Allergy Immunol; 2007 Dec; 142(1):64-9. PubMed ID: 17016059
    [Abstract] [Full Text] [Related]

  • 44. Aspirin-induced asthma and bronchial hyperresponsiveness.
    Melillo G, Padovano A, Masi C, Melillo E, Cocco G.
    Allerg Immunol (Paris); 1991 Dec; 23(10):423-7. PubMed ID: 1811646
    [Abstract] [Full Text] [Related]

  • 45. Exhaled eicosanoids following oral aspirin challenge in asthmatic patients.
    Sanak M, Kiełbasa B, Bochenek G, Szczeklik A.
    Clin Exp Allergy; 2004 Dec; 34(12):1899-904. PubMed ID: 15663565
    [Abstract] [Full Text] [Related]

  • 46. Early increase in urinary leukotriene E4 (LTE4) is dependent on allergen dose inhaled during bronchial challenge in asthmatic subjects.
    Bancalari L, Conti I, Giannessi D, Lazzerini G, Dente FL, De Caterina R, Paggiaro PL.
    Allergy; 1999 Dec; 54(12):1278-85. PubMed ID: 10688431
    [Abstract] [Full Text] [Related]

  • 47. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib.
    Gyllfors P, Bochenek G, Overholt J, Drupka D, Kumlin M, Sheller J, Nizankowska E, Isakson PC, Mejza F, Lefkowith JB, Dahlén SE, Szczeklik A, Murray JJ, Dahlén B.
    J Allergy Clin Immunol; 2003 May; 111(5):1116-21. PubMed ID: 12743579
    [Abstract] [Full Text] [Related]

  • 48. Clinical features of asthmatic patients with increased urinary leukotriene E4 excretion (hyperleukotrienuria): Involvement of chronic hyperplastic rhinosinusitis with nasal polyposis.
    Higashi N, Taniguchi M, Mita H, Kawagishi Y, Ishii T, Higashi A, Osame M, Akiyama K.
    J Allergy Clin Immunol; 2004 Feb; 113(2):277-83. PubMed ID: 14767442
    [Abstract] [Full Text] [Related]

  • 49. Urinary excretion of leukotriene E4 and 11-dehydro-thromboxane B2 in response to bronchial provocations with allergen, aspirin, leukotriene D4, and histamine in asthmatics.
    Kumlin M, Dahlén B, Björck T, Zetterström O, Granström E, Dahlén SE.
    Am Rev Respir Dis; 1992 Jul; 146(1):96-103. PubMed ID: 1320824
    [Abstract] [Full Text] [Related]

  • 50. The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions.
    Berges-Gimeno MP, Simon RA, Stevenson DD.
    Clin Exp Allergy; 2002 Oct; 32(10):1491-6. PubMed ID: 12372130
    [Abstract] [Full Text] [Related]

  • 51. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses.
    Daffern PJ, Muilenburg D, Hugli TE, Stevenson DD.
    J Allergy Clin Immunol; 1999 Sep; 104(3 Pt 1):559-64. PubMed ID: 10482828
    [Abstract] [Full Text] [Related]

  • 52. Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma.
    Shoji T, Yoshida S, Sakamoto H, Hasegawa H, Nakagawa H, Amayasu H.
    Clin Exp Allergy; 1999 Jul; 29(7):950-6. PubMed ID: 10383596
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Comparison of three inhaled non-steroidal anti-inflammatory drugs on the airway response to sodium metabisulphite and adenosine 5'-monophosphate challenge in asthma.
    Wang M, Wisniewski A, Pavord I, Knox A, Tattersfield A.
    Thorax; 1996 Aug; 51(8):799-804. PubMed ID: 8795667
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Nasal and bronchial tolerability of Rofecoxib in patients with aspirin induced asthma.
    Micheletto C, Tognella S, Guerriero M, Dal Negro R.
    Eur Ann Allergy Clin Immunol; 2006 Jan; 38(1):10-4. PubMed ID: 16544582
    [Abstract] [Full Text] [Related]

  • 58. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L, Celejewska-Wójcik N, Wójcik K, Gielicz A, Januszek R, Cholewa A, Stręk P, Sanak M.
    Allergy; 2014 Nov; 69(11):1550-9. PubMed ID: 25123806
    [Abstract] [Full Text] [Related]

  • 59. Effect of acyclovir on bronchoconstriction and urinary leukotriene E4 excretion in aspirin-induced asthma.
    Yoshida S, Sakamoto H, Yamawaki Y, Shoji T, Akahori K, Onuma K, Nakagawa H, Hasegawa H, Amayasu H.
    J Allergy Clin Immunol; 1998 Dec; 102(6 Pt 1):909-14. PubMed ID: 9847430
    [Abstract] [Full Text] [Related]

  • 60. Inhalation challenge in ASA-induced asthma.
    Dahlén B, Melillo G.
    Respir Med; 1998 Mar; 92(3):378-84. PubMed ID: 9692093
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.